Table 2.
Study | Year | Design | N | Findings |
---|---|---|---|---|
Liu et al.33 | 1994 | Retrospective | 41 | 34% of patients with visual loss had visual improvement with IV or oral corticosteroids. More benefit was seen in the patients who received IV treatment. |
Gonzales-Gay et al.8 | 1998 | Retrospective | 34 | Early treatment (within 24 hours) was the only predictor of recovery of VA. No significant difference between IV and oral treatment. |
Kupersmith et al.75 | 1999 | Prospective | 22 | 4 of 9 (44%) eyes had improved VA within 1 month of starting treatment with oral prednisone. |
Hayreh et al.22 | 2002 | Retrospective | 114 | 4% of patients had improvement of both VA and central VF on treatment. A trend toward improvement was seen with immediate treatment. |
Foroozan et al.23 | 2003 | Retrospective | 32 | 13% of patients had improvement of VA with treatment (time from onset of symptoms not specified), but none showed significant improvement in VF. |
Danesh-Meyer et al.24 | 2005 | Prospective | 34 | Patients received treatment within 10 days after onset of visual loss (mean 2 days). 15% of patients had improvement of VA of 2 or more lines. No significant improvement was seen of VF or color vision. |
GCA, giant cell arteritis; IV, intravenous; VA, visual acuity; VF, visual field.